Adasuve
- Product NDC
- 51097-001
- 11-digit product format
- 510970001
- Labeler code
- 51097
- Product ID
- 51097-001_d9a86d65-31c8-5dd9-e053-2995a90af97c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- loxapine
- Dosage form
- AEROSOL, POWDER
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Alexza Pharmaceuticals, Inc.
- Application
- NDA022549
- Marketing category
- NDA
- Marketing start
- 2022-05-31
- Marketing end
- 0000-00-00
- Substance
- LOXAPINE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51097-001 | ADASUVE (LOXAPINE) AEROSOL, POWDER [ALEXZA PHARMACEUTICALS, INC.] | 5 | Legacy NDC | 20241004_50e11732-7387-452d-b3e6-db3a431d5c4a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51097-001-02 | 51097000102 | 5 INHALER in 1 CARTON (51097-001-02) > 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) | 5 inhaler | 2022-05-31 | 0000-00-00 | No | No | Current |